首页> 外国专利> Capsule for oral administration comprising n Tert Butyl (3 - 5 - methyl - 2 - ((4 - (2) - pyrrolidin-3-yl - 1 - iletoxi) phenyl amino} pyrimidin-4-yl) amino benzenesulfonamide, microcrystalline Cellulose and sodium Stearyl fumarate; Unit dosage form; method to treat myelofibrosis; method of Preparation On; and article Preparation.

Capsule for oral administration comprising n Tert Butyl (3 - 5 - methyl - 2 - ((4 - (2) - pyrrolidin-3-yl - 1 - iletoxi) phenyl amino} pyrimidin-4-yl) amino benzenesulfonamide, microcrystalline Cellulose and sodium Stearyl fumarate; Unit dosage form; method to treat myelofibrosis; method of Preparation On; and article Preparation.

机译:包含n叔丁基[(3-5-甲基-2-((4-(2)-吡咯烷基-3-基-1-iletoxi)苯基]氨基}嘧啶-4-基)氨基]苯磺酰胺的口服胶囊,微晶纤维素和硬脂富马酸钠;单位剂型;治疗骨髓纤维化的方法;制备方法;和制品制备。

摘要

Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
机译:本文提供了用于治疗受试者的骨髓纤维化的组合物和方法。该方法包括向受试者施用有效量的化合物,该化合物为N-叔丁基-3-[(5-甲基-2-{[4-(2-吡咯烷-1-基乙氧基)苯基]氨基}嘧啶-4-基)氨基]苯磺酰胺或其药物盐或水合物。

著录项

  • 公开/公告号CL2013001252A1

    专利类型

  • 公开/公告日2014-03-28

    原文格式PDF

  • 申请/专利权人 TARGEGEN INC.;

    申请/专利号CL20130001252

  • 发明设计人 JAYAN ARVIND;CACACE JANICE;TEFFERI AYALEW;

    申请日2013-05-06

  • 分类号A61K31/506;A61K9/48;A61P7/00;

  • 国家 CL

  • 入库时间 2022-08-21 15:58:28

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号